 | |||||
| cancer | |||||
| NEWS | |||||
| FDA Approves Datopotamab Deruxtecan for Advanced Breast Cancer - Oncology Nursing News FDA approves Dato-DXd for certain HR-positive, HER2-negative metastatic breast cancers. The FDA granted approval to datopotamab deruxtecan-dlnk (Dato- ...
| |||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
No comments:
Post a Comment